Zkusit zdarma
Day One Biopharmaceuticals, Inc.

Day One Biopharmaceuticals, Inc.

DAWN
Cena:
$ 21.53
0.00 (0.00%)
Valuace
70
Růst
30
Zdraví
75
Souhrn Finanční data Pro investory Předpovědi Zprávy Dividendy Zisky Návštěvnost webu Akcionáři
Souhrn
Finanční data
Pro investory
Předpovědi
Zprávy
Dividendy
Zisky
Návštěvnost webu
Akcionáři

Zprávy

Zahraniční články
Tiskové zprávy
Dokumenty ke stáhnutí
Servier finalise l'acquisition de Day One Biopharmaceuticals

Servier finalise l'acquisition de Day One Biopharmaceuticals

8:30 23-04-2026

/PRNewswire/ -- Servier, un groupe pharmaceutique international indépendant gouverné par une fonda...

Servier completes the acquisition of Day One Biopharmaceuticals

Servier completes the acquisition of Day One Biopharmaceuticals

8:30 23-04-2026

/PRNewswire/ -- Servier, an independent international pharmaceutical group governed by a foundation,...

Servier completes the acquisition of Day One Biopharmaceuticals

Servier completes the acquisition of Day One Biopharmaceuticals

8:30 23-04-2026

Acquisition expands Servier's position in oncology with tovorafenib marketed as OJEMDATM in the U.S...

Day One Biopharmaceuticals (NASDAQ:DAWN) Sets New 1-Year High – What’s Next?

Day One Biopharmaceuticals (NASDAQ:DAWN) Sets New 1-Year High – What’s Next?

4:57 07-04-2026

Day One Biopharmaceuticals, Inc. (NASDAQ: DAWN - Get Free Report)'s share price reached a new 52-wee...

Day One Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Day One Biopharmaceuticals, Inc. - DAWN

Day One Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Day One Biopharmaceuticals, Inc. - DAWN

17:16 26-03-2026

NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., ...

Day One Biopharmaceuticals Touts OJEMDA Sales Surge, Sets $225M-$250M 2026 Outlook at TD Cowen

Day One Biopharmaceuticals Touts OJEMDA Sales Surge, Sets $225M-$250M 2026 Outlook at TD Cowen

1:07 11-03-2026

Day One Biopharmaceuticals (NASDAQ: DAWN) executives highlighted accelerating commercial momentum fo...

Are DAWN and TALK Obtaining Fair Deals for their Shareholders?

Are DAWN and TALK Obtaining Fair Deals for their Shareholders?

13:25 09-03-2026

Insiders may stand to receive substantial financial benefits not available to ordinary shareholders....

DAWN Stock Jumps 66% on $2.5B Buyout Offer From Servier

DAWN Stock Jumps 66% on $2.5B Buyout Offer From Servier

10:11 09-03-2026

Day One's stock surges 66% after Servier agrees to acquire it for $21.50 per share in a $2.5B deal, ...

Day One Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Day One Biopharmaceuticals, Inc. - DAWN

Day One Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Day One Biopharmaceuticals, Inc. - DAWN

18:25 06-03-2026

NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., ...

Stock Market Today, March 6: Energy Stocks Rise as Oil Closes Over $90 on Middle East Tensions

Stock Market Today, March 6: Energy Stocks Rise as Oil Closes Over $90 on Middle East Tensions

17:49 06-03-2026

The S&P 500 (^GSPC 1.33%) fell 1.33% to 6,740.02, the Nasdaq Composite (^IXIC 1.59%) slid 1.59% to 2...

SHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of Day One Biopharmaceuticals, Inc. (DAWN)

SHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of Day One Biopharmaceuticals, Inc. (DAWN)

16:01 06-03-2026

Bala Cynwyd, Pennsylvania--(Newsfile Corp. - March 6, 2026) - Law office of Brodsky & Smith announce...

Shareholder Alert: The Ademi Firm investigates whether Day One Biopharmaceuticals, Inc. is obtaining a Fair Price for its Public Shareholders

Shareholder Alert: The Ademi Firm investigates whether Day One Biopharmaceuticals, Inc. is obtaining a Fair Price for its Public Shareholders

14:45 06-03-2026

MILWAUKEE, March 6, 2026 /PRNewswire/ -- Ademi LLP is investigating Day One (NASDAQ: DAWN) for possi...

$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Day One Biopharmaceuticals, Inc. (NASDAQ: DAWN)

$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Day One Biopharmaceuticals, Inc. (NASDAQ: DAWN)

13:12 06-03-2026

NEW YORK, March 6, 2026 /PRNewswire/ -- Class Action Attorney Juan Monteverde  with Monteverde & As...

DAWN Stock Alert: Halper Sadeh LLC is Investigating Whether Day One Biopharmaceuticals, Inc. is Obtaining a Fair Price for its Shareholders

DAWN Stock Alert: Halper Sadeh LLC is Investigating Whether Day One Biopharmaceuticals, Inc. is Obtaining a Fair Price for its Shareholders

10:34 06-03-2026

NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating the sale ...

Day One Shares Surge After $2.5B Servier Deal

Day One Shares Surge After $2.5B Servier Deal

10:04 06-03-2026

Day One Biopharmaceuticals, Inc. (NASDAQ: DAWN) shares are trading higher Friday after the company a...

Servier to buy Day One Biopharmaceuticals for total equity value of $2.5 billion

Servier to buy Day One Biopharmaceuticals for total equity value of $2.5 billion

8:38 06-03-2026

Independent ​international ‌pharmaceutical group ​Servier ​will ⁠buy ​Day One ​Biophar...

Servier and Day One Biopharmaceuticals announce acquisition to expand Servier's rare oncology portfolio

Servier and Day One Biopharmaceuticals announce acquisition to expand Servier's rare oncology portfolio

8:30 06-03-2026

SURESNES, France and BRISBANE, Calif., March 06, 2026 (GLOBE NEWSWIRE) -- Servier, an independent in...

Day One Biopharmaceuticals: 'Strong Buy,' Several 2026 Milestones In Play Plus OJEMDA Growth

Day One Biopharmaceuticals: 'Strong Buy,' Several 2026 Milestones In Play Plus OJEMDA Growth

14:41 05-03-2026

Day One Biopharmaceuticals is maintained at a "Strong Buy" rating, driven by robust pipeline progres...

Day One Biopharmaceuticals, Inc. (DAWN) Reports Q4 Loss, Beats Revenue Estimates

Day One Biopharmaceuticals, Inc. (DAWN) Reports Q4 Loss, Beats Revenue Estimates

20:31 24-02-2026

Day One Biopharmaceuticals, Inc. (DAWN) came out with a quarterly loss of $0.2 per share versus the ...

Day One Reports Fourth Quarter and Full Year 2025 Financial Results and Reaffirms 2026 Outlook and Revenue Guidance

Day One Reports Fourth Quarter and Full Year 2025 Financial Results and Reaffirms 2026 Outlook and Revenue Guidance

16:00 24-02-2026

OJEMDA™ 2025 momentum reflected by Q4 and full year net product revenues of $52.8 million and $155...

close

DAY ONE TO REPORT FOURTH QUARTER AND FULL-YEAR 2025 FINANCIAL RESULTS TUESDAY, FEBRUARY 24, 2026

10-02-2026
BRISBANE, CALIF., FEB. 10, 2026 (GLOBE NEWSWIRE) -- DAY ONE BIOPHARMACEUTICALS (NASDAQ: DAWN) (“DA...
Více zde

DAY ONE ANNOUNCES PRELIMINARY 2025 OJEMDA™ NET PRODUCT REVENUE AND PROVIDES 2026 NET PRODUCT REVENUE GUIDANCE

11-01-2026
PRELIMINARY 2025 NET PRODUCT REVENUE OF $155.4 MILLION, REPRESENTING 172% YEAR-OVER-YEAR GROWTH; OJE...
Více zde

DAY ONE COMPLETES ACQUISITION OF MERSANA THERAPEUTICS

06-01-2026
BRISBANE, CALIF., JAN. 06, 2026 (GLOBE NEWSWIRE) -- DAY ONE BIOPHARMACEUTICALS, INC. (NASDAQ: DAWN) ...
Více zde

DAY ONE TO PRESENT AT THE 44TH ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE

16-12-2025
BRISBANE, CALIF., DEC. 16, 2025 (GLOBE NEWSWIRE) -- DAY ONE BIOPHARMACEUTICALS, INC. (NASDAQ: DAWN) ...
Více zde

DAY ONE ANNOUNCES THREE YEAR FOLLOW-UP DATA FROM OJEMDA™ (TOVORAFENIB) PHASE 2 FIREFLY-1 TRIAL AT THE 2025 SOCIETY FOR NEURO-ONCOLOGY (SNO) ANNUAL MEETING

24-11-2025
UPDATED DATA EXPANDS CLINICALLY MEANINGFUL RESULTS AVAILABLE FROM FIREFLY-1 PIVOTAL TRIAL  77% OF P...
Více zde

DAY ONE TO PARTICIPATE IN THE PIPER SANDLER 37TH ANNUAL HEALTHCARE CONFERENCE

18-11-2025
BRISBANE, CALIF., NOV. 18, 2025 (GLOBE NEWSWIRE) -- DAY ONE BIOPHARMACEUTICALS, INC. (NASDAQ: DAWN) ...
Více zde

DAY ONE TO ACQUIRE MERSANA THERAPEUTICS TO ADVANCE MISSION TO BRING NEW MEDICINES TO PEOPLE OF ALL AGES WITH LIFE-THREATENING DISEASES

13-11-2025
ACQUISITION EXPANDS DAY ONE'S PORTFOLIO WITH NOVEL ANTIBODY-DRUG CONJUGATE (ADC) EMILTATUG LEDADOTIN...
Více zde

DAY ONE ANNOUNCES NEW OJEMDA™ (TOVORAFENIB) DATA TO BE PRESENTED IN ORAL SESSION AT THE 2025 SOCIETY FOR NEURO-ONCOLOGY (SNO) ANNUAL MEETING

10-11-2025
THREE-YEAR FOLLOW-UP DATA FROM FIREFLY-1 DEMONSTRATES DURABLE RESPONSES WITH EVIDENCE OF CLINICAL ST...
Více zde

DAY ONE REPORTS THIRD QUARTER 2025 FINANCIAL RESULTS AND CORPORATE PROGRESS

04-11-2025
COMMERCIAL EXECUTION DELIVERS BEST QUARTER LAUNCH-TO-DATE WITH GROWTH ACROSS ALL DIMENSIONS OF CORE ...
Více zde

DAY ONE TO REPORT THIRD QUARTER 2025 FINANCIAL RESULTS TUESDAY, NOVEMBER 4, 2025

21-10-2025
BRISBANE, CALIF., OCT. 21, 2025 (GLOBE NEWSWIRE) -- DAY ONE BIOPHARMACEUTICALS (NASDAQ: DAWN) (“DA...
Více zde

DAY ONE REPORTS SECOND QUARTER 2025 FINANCIAL RESULTS AND CORPORATE PROGRESS

05-08-2025
OJEMDA™  (TOVORAFENIB) NET PRODUCT REVENUE OF $33.6 MILLION IN Q2 2025, A 10% QUARTER-OVER-QUARTE...
Více zde

DAY ONE TO REPORT SECOND QUARTER 2025 FINANCIAL RESULTS TUESDAY, AUGUST 5, 2025

22-07-2025
BRISBANE, CALIF., JULY 22, 2025 (GLOBE NEWSWIRE) -- DAY ONE BIOPHARMACEUTICALS (NASDAQ: DAWN) (“DA...
Více zde

DAY ONE APPOINTS MICHAEL VASCONCELLES, M.D., AS HEAD OF RESEARCH AND DEVELOPMENT

10-06-2025
DR. MICHAEL VASCONCELLES BRINGS MORE THAN 25 YEARS OF EXTENSIVE ONCOLOGY RESEARCH, DEVELOPMENT AND H...
Více zde

DAY ONE REPORTS FIRST QUARTER 2025 FINANCIAL RESULTS AND CORPORATE PROGRESS

06-05-2025
OJEMDA™  (TOVORAFENIB) PRESCRIPTIONS GREW 16% IN Q1 2025 COMPARED TO Q4 2024 ACHIEVED Q1 2025 OJE...
Více zde

DAY ONE TO REPORT FIRST QUARTER 2025 FINANCIAL RESULTS TUESDAY, MAY 6, 2025

22-04-2025
BRISBANE, CALIF., APRIL 22, 2025 (GLOBE NEWSWIRE) -- DAY ONE BIOPHARMACEUTICALS (NASDAQ: DAWN) (“D...
Více zde

UNDER ARMOUR APPOINTS DAWN N. FITZPATRICK, EUGENE D.

15-04-2025
BALTIMORE , APRIL 15, 2025 /PRNEWSWIRE/ -- UNDER ARMOUR, INC. (NYSE: UA, UAA) ANNOUNCED TODAY THAT,...
Více zde

DAY ONE REPORTS FOURTH QUARTER AND FULL YEAR 2024 FINANCIAL RESULTS AND CORPORATE PROGRESS

25-02-2025
ACHIEVED Q4 2024 AND FULL YEAR 2024 OJEMDA™ (TOVORAFENIB) NET PRODUCT REVENUES OF $29.0 MILLION A...
Více zde

DAY ONE TO REPORT FOURTH QUARTER AND FULL-YEAR 2024 FINANCIAL RESULTS TUESDAY, FEBRUARY 25, 2025

11-02-2025
BRISBANE, CALIF., FEB. 11, 2025 (GLOBE NEWSWIRE) -- DAY ONE BIOPHARMACEUTICALS (NASDAQ: DAWN) (“DA...
Více zde

DAY ONE TO PRESENT AT THE 43RD ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE

17-12-2024
BRISBANE, CALIF., DEC. 17, 2024 (GLOBE NEWSWIRE) -- DAY ONE BIOPHARMACEUTICALS (NASDAQ: DAWN) (“DA...
Více zde

DAY ONE ANNOUNCES RETIREMENT OF DR. SAMUEL BLACKMAN, CO-FOUNDER AND HEAD OF RESEARCH & DEVELOPMENT

20-11-2024
DR. BLACKMAN'S DEPARTURE PLANNED FOR END OF 2024 COMPANY'S SEARCH FOR A NEW HEAD OF R&D IS ONGOING B...
Více zde

DAY ONE TO PARTICIPATE IN THE PIPER SANDLER 36TH ANNUAL HEALTHCARE CONFERENCE

18-11-2024
BRISBANE, CALIF., NOV. 18, 2024 (GLOBE NEWSWIRE) -- DAY ONE BIOPHARMACEUTICALS, INC. (NASDAQ: DAWN) ...
Více zde

DAY ONE REPORTS THIRD QUARTER 2024 FINANCIAL RESULTS AND CORPORATE PROGRESS

30-10-2024
ACHIEVED $20.1 MILLION IN OJEMDA TM (TOVORAFENIB) NET PRODUCT REVENUE ENDED THE THIRD QUARTER WITH $...
Více zde

SUNDECK 3200 HERALDS IN A NEW DAWN FOR HURRICANE BOATS

30-10-2024
ELKHART, IND. , OCT. 30, 2024 /PRNEWSWIRE/ -- HURRICANE BOATS, LEGENDARY INNOVATOR IN VERSATILE DECK...
Více zde

DAY ONE TO REPORT THIRD QUARTER 2024 FINANCIAL RESULTS WEDNESDAY, OCTOBER 30, 2024

16-10-2024
BRISBANE, CALIF., OCT. 16, 2024 (GLOBE NEWSWIRE) -- DAY ONE BIOPHARMACEUTICALS (NASDAQ: DAWN) (“DA...
Více zde

DAY ONE REPORTS SECOND QUARTER 2024 FINANCIAL RESULTS AND CORPORATE PROGRESS

30-07-2024
ACHIEVED $8.2 MILLION IN OJEMDA TM (TOVORAFENIB) NET PRODUCT REVENUES IN INITIAL 2 MONTHS OF LAUNCH...
Více zde

DAY ONE ANNOUNCES OVERSUBSCRIBED $175.0 MILLION PRIVATE PLACEMENT

30-07-2024
BRISBANE, CALIF., JULY 30, 2024 (GLOBE NEWSWIRE) -- DAY ONE BIOPHARMACEUTICALS, INC. (NASDAQ: DAWN) ...
Více zde

IPSEN AND DAY ONE ENTER INTO EXCLUSIVE EX-U.S. LICENSING AGREEMENT TO COMMERCIALIZE TOVORAFENIB FOR THE MOST COMMON CHILDHOOD BRAIN TUMOR

25-07-2024
PARIS, FRANCE, AND BRISBANE, CALIFORNIA U.S., 25 JULY 2024 - IPSEN (EURONEXT: IPN; ADR: IPSEY) AND D...
Více zde

DAY ONE EXPANDS PIPELINE WITH POTENTIAL FIRST-IN-CLASS CLINICAL-STAGE ANTIBODY DRUG CONJUGATE (ADC) TARGETING PTK7 IN SOLID TUMORS FOR ADULT AND PEDIATRIC CANCERS

18-06-2024
DAY ONE RECEIVES EXCLUSIVE LICENSE FOR DEVELOPMENT AND COMMERCIALIZATION OF MTX-13 (DAY301), WHICH R...
Více zde

DAY ONE ANNOUNCES SALE OF PRIORITY REVIEW VOUCHER FOR $108 MILLION

30-05-2024
BRISBANE, CALIF., MAY 30, 2024 (GLOBE NEWSWIRE) -- DAY ONE BIOPHARMACEUTICALS (NASDAQ: DAWN) (“DAY...
Více zde

DAY ONE REPORTS FIRST QUARTER 2024 FINANCIAL RESULTS AND CORPORATE PROGRESS

06-05-2024
OJEMDA™ (TOVORAFENIB) LAUNCH UNDERWAY FOLLOWING U.S. FDA ACCELERATED APPROVAL FOR RELAPSED OR REFR...
Více zde

close

Datum Typ Otevřít EDGAR Stáhnout dokument
2026-01-12 00:00:008-KStáhnout
2026-01-06 00:00:008-KStáhnout
2025-11-24 00:00:008-KStáhnout
2025-11-13 00:00:008-KStáhnout
2025-11-04 00:00:008-KStáhnout
2025-11-04 00:00:0010-QStáhnout
2025-10-10 01:00:008-KStáhnout
2025-10-10 00:00:008-KStáhnout
2025-08-05 01:00:008-KStáhnout
2025-08-05 01:00:0010-QStáhnout
2025-08-05 00:00:008-KStáhnout
2025-08-05 00:00:0010-QStáhnout
2025-06-03 01:00:008-KStáhnout
2025-06-03 00:00:008-KStáhnout
2025-05-06 01:00:008-KStáhnout
2025-05-06 01:00:0010-QStáhnout
2025-05-06 00:00:008-KStáhnout
2025-05-06 00:00:0010-QStáhnout
2025-02-25 00:00:008-KStáhnout
2025-02-25 00:00:0010-KStáhnout
2025-02-24 23:00:008-KStáhnout
2025-02-24 23:00:0010-KStáhnout
2025-01-13 00:00:008-KStáhnout
2025-01-12 23:00:008-KStáhnout
2024-11-20 00:00:008-KStáhnout
2024-11-19 23:00:008-KStáhnout
2024-10-30 00:00:008-KStáhnout
2024-10-30 00:00:0010-QStáhnout
2024-10-29 23:00:008-KStáhnout
2024-10-29 23:00:0010-QStáhnout
2024-08-02 01:00:0010-QStáhnout
2024-08-02 00:00:0010-QStáhnout
2024-07-30 01:00:008-KStáhnout
2024-07-30 00:00:008-KStáhnout
2024-07-25 01:00:008-KStáhnout
2024-07-25 00:00:008-KStáhnout
2024-06-18 01:00:008-KStáhnout
2024-06-18 00:00:008-KStáhnout
2024-06-12 01:00:008-KStáhnout
2024-06-12 00:00:008-KStáhnout
2024-05-30 01:00:008-KStáhnout
2024-05-30 00:00:008-KStáhnout
2024-05-24 01:00:008-KStáhnout
2024-05-24 00:00:008-KStáhnout
2024-05-06 01:00:008-KStáhnout
2024-05-06 01:00:0010-QStáhnout
2024-05-06 00:00:008-KStáhnout
2024-05-06 00:00:0010-QStáhnout
2024-04-24 01:00:008-KStáhnout
2024-04-24 00:00:008-KStáhnout
2024-03-07 00:00:008-KStáhnout
2024-03-06 23:00:008-KStáhnout
2024-02-26 00:00:008-KStáhnout
2024-02-26 00:00:0010-KStáhnout
2024-02-25 23:00:008-KStáhnout
2024-02-25 23:00:0010-KStáhnout
2024-01-17 00:00:008-KStáhnout
2024-01-16 23:00:008-KStáhnout
2024-01-08 00:00:008-KStáhnout
2024-01-07 23:00:008-KStáhnout
2023-12-08 00:00:008-KStáhnout
2023-12-07 23:00:008-KStáhnout
2023-11-17 00:00:008-KStáhnout
2023-11-16 23:00:008-KStáhnout
2023-11-15 00:00:008-KStáhnout
2023-11-14 23:00:008-KStáhnout
2023-11-06 00:00:008-KStáhnout
2023-11-06 00:00:0010-QStáhnout
2023-11-05 23:00:008-KStáhnout
2023-11-05 23:00:0010-QStáhnout
2023-10-30 00:00:008-KStáhnout
2023-10-29 23:00:008-KStáhnout
2023-09-11 01:00:008-KStáhnout
2023-09-11 00:00:008-KStáhnout
2023-08-16 01:00:008-KStáhnout
2023-08-16 00:00:008-KStáhnout
2023-08-07 01:00:008-KStáhnout
2023-08-07 01:00:0010-QStáhnout
2023-08-07 00:00:008-KStáhnout
2023-08-07 00:00:0010-QStáhnout
2023-06-23 01:00:008-KStáhnout
2023-06-23 00:00:008-KStáhnout
2023-06-12 01:00:008-KStáhnout
2023-06-12 00:00:008-KStáhnout
2023-06-07 01:00:008-KStáhnout
2023-06-07 00:00:008-KStáhnout
2023-06-06 01:00:008-KStáhnout
2023-06-06 00:00:008-KStáhnout
2023-06-05 01:00:008-KStáhnout
2023-06-05 00:00:008-KStáhnout
2023-05-01 01:00:008-KStáhnout
2023-05-01 01:00:0010-QStáhnout
2023-05-01 00:00:008-KStáhnout
2023-05-01 00:00:0010-QStáhnout
2023-04-20 01:00:008-KStáhnout
2023-04-20 00:00:008-KStáhnout
2023-03-20 00:00:008-KStáhnout
2023-03-19 23:00:008-KStáhnout
2023-03-06 00:00:008-KStáhnout
2023-03-06 00:00:0010-KStáhnout
2023-03-05 23:00:008-KStáhnout
2023-03-05 23:00:0010-KStáhnout
2023-02-23 00:00:008-KStáhnout
2023-02-22 23:00:008-KStáhnout
2023-01-09 00:00:008-KStáhnout
2023-01-08 23:00:008-KStáhnout
2022-11-07 00:00:008-KStáhnout
2022-11-07 00:00:0010-QStáhnout
2022-11-06 23:00:008-KStáhnout
2022-11-06 23:00:0010-QStáhnout
2022-08-04 01:00:008-KStáhnout
2022-08-04 01:00:0010-QStáhnout
2022-08-04 00:00:008-KStáhnout
2022-08-04 00:00:0010-QStáhnout
2022-06-24 01:00:008-KStáhnout
2022-06-24 00:00:008-KStáhnout
2022-06-16 01:00:008-KStáhnout
2022-06-16 00:00:008-KStáhnout
2022-06-13 01:00:008-KStáhnout
2022-06-13 00:00:008-KStáhnout
2022-05-12 01:00:008-KStáhnout
2022-05-12 01:00:0010-QStáhnout
2022-05-12 00:00:008-KStáhnout
2022-05-12 00:00:0010-QStáhnout
2022-04-13 01:00:008-KStáhnout
2022-04-13 00:00:008-KStáhnout
2022-03-07 00:00:008-KStáhnout
2022-03-07 00:00:0010-KStáhnout
2022-03-06 23:00:008-KStáhnout
2022-03-06 23:00:0010-KStáhnout
2022-01-05 00:00:008-KStáhnout
2022-01-04 23:00:008-KStáhnout
2021-11-08 00:00:008-KStáhnout
2021-11-08 00:00:0010-QStáhnout
2021-11-07 23:00:008-KStáhnout
2021-11-07 23:00:0010-QStáhnout
2021-11-03 00:00:008-KStáhnout
2021-11-02 23:00:008-KStáhnout
2021-08-17 01:00:008-KStáhnout
2021-08-17 00:00:008-KStáhnout
2021-08-10 01:00:008-KStáhnout
2021-08-10 01:00:0010-QStáhnout
2021-08-10 00:00:008-KStáhnout
2021-08-10 00:00:0010-QStáhnout
preloader